MetaADEDB 2.0 @ LMMD
nelarabine
(IXOXBSCIXZEQEQ-UHTZMRCNSA-N)
Structure
SMILES
OC[C@H]1O[C@H]([C@H]([C@@H]1O)O)n1cnc2c1nc(N)nc2OC
Type(s)
Approved; Investigational
ATC code(s)
L01BB07
Molecular Formula:
C11H15N5O5
Molecular Weight:
297.267
Log P:
-1.3902
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
4
TPSA:
148.77
CAS Number(s):
7803-88-5; 121032-29-9
Synonym(s)
1.
nelarabine
2.
2-amino-6-methoxypurine arabinoside
3.
2-amino-9-beta-D-arabinofuranosyl-6-methoxy-9H-purine
4.
506U78
5.
Arranon
6.
GW506U78
7.
compound 506U78
External Link(s)
MeSHC104457
PubChem Compound3011155
BindingDB50247985
ChEBI63612
CHEMBLCHEMBL1201112
DrugBankDB01280
DrugCentral1892
IUPHAR/BPS Guide to PHARMACOLOGY7090
KEGGdr:D05134
Therapeutic Target DatabaseD0B8UJ
ZINC3823492
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1Alanine Aminotransferase IncreasedFAERS: 7OFFSIDES
US FAERS
2Disease ProgressionFAERS: 7OFFSIDES
US FAERS
3HeadacheFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
4InfectionFAERS: 6SIDER
US FAERS
5nervous system disorderFAERS: 6
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
6AbasiaFAERS: 5OFFSIDES
US FAERS
7LeukoencephalopathyFAERS: 5OFFSIDES
SIDER
US FAERS
8VertigoFAERS: 5US FAERS
9AstheniaFAERS: 4OFFSIDES
SIDER
US FAERS
10Blood creatine phosphokinase increasedFAERS: 4OFFSIDES
SIDER
US FAERS
11DizzinessFAERS: 4SIDER
US FAERS
12Guillain-Barre SyndromeFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
13Memory impairmentFAERS: 4US FAERS
14ParesisFAERS: 4US FAERS
15PneumoniaFAERS: 4
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
16PolyneuropathyFAERS: 4OFFSIDES
US FAERS
17Altered state of consciousnessFAERS: 3OFFSIDES
SIDER
US FAERS
18ErythemaFAERS: 3US FAERS
19Febrile NeutropeniaFAERS: 3SIDER
US FAERS
20HyperreflexiaFAERS: 3US FAERS
21HyporeflexiaFAERS: 3SIDER
US FAERS
22MalaiseFAERS: 3US FAERS
23Malignant neoplasm progressionFAERS: 3OFFSIDES
US FAERS
24Mental status changesFAERS: 3US FAERS
25NeutropeniaFAERS: 3SIDER
US FAERS
26PainFAERS: 320528871CTD
SIDER
US FAERS
27Septic ShockFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
28SomnolenceFAERS: 3SIDER
US FAERS
29Ventricular DysfunctionFAERS: 3US FAERS
30Acute polyneuropathyFAERS: 2US FAERS
31Aspartate Aminotransferase IncreasedFAERS: 2SIDER
US FAERS
32AtaxiaFAERS: 2OFFSIDES
SIDER
US FAERS
33Bladder dysfunctionFAERS: 2US FAERS
34Blast cell count increasedFAERS: 2OFFSIDES
US FAERS
35Chemical eye injuryFAERS: 2US FAERS
36CytopeniaFAERS: 2US FAERS
37DehydrationFAERS: 2SIDER
US FAERS
38Depressed Level of ConsciousnessFAERS: 2SIDER
US FAERS
39Disease recurrenceFAERS: 2US FAERS
40Drug ineffectiveFAERS: 2US FAERS
41General physical health deteriorationFAERS: 2US FAERS
42Histiocytosis haematophagicFAERS: 2US FAERS
43HypoventilationFAERS: 2US FAERS
44LethargyFAERS: 2SIDER
US FAERS
45LeukocytosisFAERS: 2US FAERS
46MonoplegiaFAERS: 2US FAERS
47MyalgiaFAERS: 2SIDER
US FAERS
48MyelitisFAERS: 2OFFSIDES
US FAERS
49NauseaFAERS: 2SIDER
US FAERS
50NeuralgiaFAERS: 2SIDER
US FAERS
51PancytopeniaFAERS: 2US FAERS
52QuadriplegiaFAERS: 2OFFSIDES
US FAERS
53RhabdomyolysisFAERS: 2OFFSIDES
SIDER
US FAERS
54TremorFAERS: 2SIDER
US FAERS
55VomitingFAERS: 2SIDER
US FAERS
56Accidental exposure to productFAERS: 1US FAERS
57Acute kidney injuryFAERS: 1US FAERS
58AgitationFAERS: 1US FAERS
59Blood count abnormalFAERS: 1US FAERS
60Blood creatinine increasedFAERS: 1SIDER
US FAERS
61Blood lactate dehydrogenase increasedFAERS: 1US FAERS
62Blood potassiumFAERS: 1US FAERS
63Burning sensationFAERS: 1SIDER
US FAERS
64CardiotoxicityFAERS: 1US FAERS
65CholestasisFAERS: 1US FAERS
66ColitisFAERS: 1US FAERS
67CystitisFAERS: 1US FAERS
68DeafnessFAERS: 1US FAERS
69Decreased vibratory senseFAERS: 1US FAERS
70DeliriumFAERS: 1US FAERS
71DementiaFAERS: 1US FAERS
72DemyelinationFAERS: 1OFFSIDES
SIDER
US FAERS
73DysarthriaFAERS: 1SIDER
US FAERS
74DysuriaFAERS: 1US FAERS
75Ejection Fraction DecreasedFAERS: 1US FAERS
76Expired product administeredFAERS: 1US FAERS
77ExtravasationFAERS: 1US FAERS
78Eye irritationFAERS: 1US FAERS
79HepatosplenomegalyFAERS: 1US FAERS
80HypersomniaFAERS: 1US FAERS
81IncontinenceFAERS: 1OFFSIDES
US FAERS
82InflammationFAERS: 1US FAERS
83Infusion site painFAERS: 1US FAERS
84MyositisFAERS: 1US FAERS
85PancreatitisFAERS: 1US FAERS
86ParaparesisFAERS: 1OFFSIDES
US FAERS
87ParaplegiaFAERS: 120658590CTD
OFFSIDES
US FAERS
88Peripheral motor neuropathyFAERS: 1SIDER
US FAERS
89Pulmonary arterial hypertensionFAERS: 1US FAERS
90RadiculopathyFAERS: 1US FAERS
91Respiratory FailureFAERS: 1US FAERS
92Romberg test positiveFAERS: 1US FAERS
93SepsisFAERS: 1SIDER
US FAERS
94Somatosensory evoked potentials abnormalFAERS: 1US FAERS
95Supraventricular tachycardiaFAERS: 1OFFSIDES
US FAERS
96Transaminases increasedFAERS: 1SIDER
US FAERS
97Urinary IncontinenceFAERS: 1US FAERS
98VasculitisFAERS: 1US FAERS
99Ventricular arrhythmiaFAERS: 1US FAERS
100Visual ImpairmentFAERS: 1US FAERS
101White blood cell count decreasedFAERS: 1US FAERS
102jaundiceFAERS: 1US FAERS
103Abdominal PainSIDER
104AbuliaOFFSIDES
105Adverse eventOFFSIDES
106Aldolase increasedOFFSIDES
107AmnesiaSIDER
108Anal FissureOFFSIDES
109AnorexiaSIDER
110AphasiaSIDER
111ArthralgiaSIDER
112BK virus infectionOFFSIDES
113Back PainSIDER
114Blood albumin decreasedSIDER
115Blood and lymphatic system disordersSIDER
116Blood glucose decreasedSIDER
117Blood magnesium decreasedSIDER
118Blood potassium decreasedSIDER
119Blurred visionOFFSIDES
120Bulbar palsyOFFSIDES
121Chest PainSIDER
122ChillsSIDER
123Complications of transplant surgeryOFFSIDES
124ConfabulationOFFSIDES
125ConstipationSIDER
126CystSIDER
127Diastolic dysfunctionOFFSIDES
128DiplegiaCanada Vigilance: 1Canada Vigilance
129DrowsinessOFFSIDES
130DysgeusiaSIDER
131DysphoniaOFFSIDES
132EpistaxisSIDER
133FatigueSIDER
134Feeling abnormalSIDER
135FormicationOFFSIDES
136Gastrointestinal PainSIDER
137GliosisCanada Vigilance: 1Canada Vigilance
138HemiparesisSIDER
139HydrocephalusSIDER
140HypomaniaOFFSIDES
141HypotensionSIDER
142InfestationSIDER
143Infusion site mobility decreasedOFFSIDES
144Intention tremorOFFSIDES
145Leukemia, T-Cell20528871CTD
146Leukopenia neonatalOFFSIDES
147LeukopeniaSIDER
148Loss of proprioceptionOFFSIDES
149MalnutritionSIDER
150MeningitisCanada Vigilance: 1Canada Vigilance
151Mental RetardationSIDER
152MononeuritisOFFSIDES
153Muscle WeaknessOFFSIDES
154Musculoskeletal discomfortSIDER
155Neck PainCanada Vigilance: 1Canada Vigilance
156Nerve DegenerationCanada Vigilance: 1Canada Vigilance
157NeuritisSIDER
158NeuropathySIDER
159Non-cardiac chest painSIDER
160NystagmusSIDER
161Ocular cancer metastaticOFFSIDES
162Oropharyngeal painOFFSIDES
163Peripheral Nervous System Diseases24664478CTD
164PetechiaeSIDER
165PneumothoraxSIDER
166Precursor T-Cell Lymphoblastic Leukemia-Lymphoma16831976
20658590
CTD
167Productive CoughOFFSIDES
168Residual urineOFFSIDES
169Respiratory arrestSIDER
170SciaticaSIDER
171Sinus TachycardiaSIDER
172Sinus headacheSIDER
173SinusitisSIDER
174Status EpilepticusSIDER
175StomatitisSIDER
176Superior Vena Cava SyndromeOFFSIDES
177ThrombocytopeniaSIDER
178VIIth nerve paralysisOFFSIDES
179Ventricular FibrillationOFFSIDES
180WheezingSIDER
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120141

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.